{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:05:11Z","timestamp":1792854311703,"version":"4.5.0"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara"},{"id":[{"id":"https:\/\/ror.org\/00afdp487","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: High-grade serous ovarian cancer (HGSOC) represents the most aggressive subtype of epithelial ovarian cancer and is frequently diagnosed at advanced stages. Increasing evidence suggests that systemic inflammation plays an important role in tumor progression and clinical outcomes. This study aimed to evaluate the association between preoperative systemic inflammatory indices and tumor burden, perioperative outcomes, and recurrence risk in patients with HGSOC undergoing primary debulking surgery. Methods: We conducted a retrospective study including 125 patients with histopathologically confirmed HGSOC who underwent primary debulking surgery between January 2020 and December 2025. Preoperative hematological parameters obtained within 24 h before surgery were used to calculate inflammatory indices including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI). Associations between inflammatory markers, clinicopathological characteristics, perioperative outcomes, and recurrence were analyzed using non-parametric tests and logistic regression models. Results: The mean patient age was 53.66 \u00b1 9.14 years, and most patients presented with advanced disease (FIGO III\u2013IV: 70.4%). Patients with T3 tumors showed significantly higher monocyte (0.66 vs. 0.50 \u00d7 109\/L, p = 0.003), neutrophil (5.43 vs. 4.99 \u00d7 109\/L, p = 0.042), and platelet counts (325 vs. 280 \u00d7 109\/L, p = 0.006) and lower lymphocyte counts (1.79 vs. 1.96 \u00d7 109\/L, p = 0.009). Composite inflammatory indices were also increased in advanced disease, including PLR (177 vs. 153, p = 0.009), AISI (492 vs. 341, p = 0.002), and SIRI (1.65 vs. 1.18, p = 0.018). Patients requiring postoperative blood transfusion had higher neutrophil counts (7.65 vs. 4.97 \u00d7 109\/L, p &lt; 0.001) and elevated SIRI (2.56 vs. 1.55, p &lt; 0.001). Patients with recurrence had significantly higher platelet counts (339 vs. 293 \u00d7 109\/L, p = 0.001) and SII values (2849 vs. 2586, p = 0.012). In multivariate analysis, SII remained independently associated with recurrence (OR 1.022 per 100-unit increase; 95% CI 1.002\u20131.043; p = 0.033) together with advanced FIGO stages (OR 2.863; 95% CI 1.011\u20138.104; p = 0.048). Conclusions: Preoperative systemic inflammatory markers are significantly associated with tumor burden, surgical outcomes, and recurrence risk in HGSOC. An elevated SII appears to be an independent predictor of recurrence and may represent a practical biomarker for improving preoperative risk stratification and postoperative surveillance.<\/jats:p>","DOI":"10.3390\/diseases14040131","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:19:32Z","timestamp":1775434772000},"page":"131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative Systemic Inflammatory Indices and Their Association with Tumor Burden and Surgical Outcomes in High-Grade Serous Ovarian Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Alexandru Marius","family":"Petrusan","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Department of Surgical Oncology and Gynecologic Oncology, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Department of Surgical Oncology, \u201cProf. Dr. I. Chiricuta\u201d Institute of Oncology, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-1198","authenticated-orcid":false,"given":"Catalin Vladut Ionut","family":"Feier","sequence":"additional","affiliation":[{"name":"Abdominal Surgery and Phlebology Research Center, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, 300041 Timi\u015foara, Romania"},{"name":"First Surgery Clinic, \u201cPius Brinzeu\u201d Clinical Emergency Hospital, 300723 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-0405","authenticated-orcid":false,"given":"Calin","family":"Muntean","sequence":"additional","affiliation":[{"name":"Medical Informatics and Biostatistics, Department III-Functional Sciences, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, Eftimie Murgu Square No. 2, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8647-1003","authenticated-orcid":false,"given":"Vasile","family":"Gaborean","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Research Center, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, 300041 Timi\u015foara, Romania"},{"name":"Department of Surgical Semiology, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Stefan","family":"Petrusan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos Stefan","family":"Morariu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, \u201cProf. Dr. I. Chiricuta\u201d Institute of Oncology, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut Flaviu","family":"Faur","sequence":"additional","affiliation":[{"name":"IInd Surgery Clinic, Timisoara Emergency County Hospital, 300723 Timi\u015foara, Romania"},{"name":"X Department of General Surgery, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaviana Monique","family":"Faur","sequence":"additional","affiliation":[{"name":"Department of Doctoral Studies, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy Timi\u015foara, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patriciu","family":"Achimas-Cadariu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology and Gynecologic Oncology, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Department of Surgical Oncology, \u201cProf. Dr. I. Chiricuta\u201d Institute of Oncology, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"ref_3","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: Recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Reuss","year":"2009","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_10","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ctrv.2015.10.003","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis","volume":"41","author":"Nishijima","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12094-011-0687-9","article-title":"Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer","volume":"13","author":"Asher","year":"2011","journal-title":"Clin. Transl. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): An open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3946320231178769","DOI":"10.1177\/03946320231178769","article-title":"Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators\u2014A review","volume":"37","author":"Dinca","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, Y., Hu, Z., Ye, Y., Wu, H., Sun, W., and Wang, N. (2025). Association of aggregate index of systemic inflammation with increased all-cause and cardiovascular mortality in female cancer patients. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1552341"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ohanoglu Cetinel, K., Guner, G., Karabudak, C.B., Zeynalli, E., and Yavuz Sen, S. (2026). Dynamic changes in prognostic nutritional index and systemic immune-inflammation index predict survival following debulking surgery in ovarian cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1720075"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Forget, P., Khalifa, C., Defour, J.P., Latinne, D., Van Pel, M.C., and De Kock, M. (2017). What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res. Notes, 10.","DOI":"10.1186\/s13104-016-2335-5"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3802\/jgo.2012.23.4.265","article-title":"Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer","volume":"23","author":"Raungkaewmanee","year":"2012","journal-title":"J. Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Zhou, S., Liu, Y., Zhai, L., and Sun, X. (2018). Prognostic value of systemic inflammatory markers in ovarian Cancer: A PRISMA-compliant meta-analysis and systematic review. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4318-5"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13048-025-01626-1","article-title":"Prognostic significance of systemic immune inflammation index for ovarian cancer: An updated systematic review and meta-analysis","volume":"18","author":"Chu","year":"2025","journal-title":"J. Ovarian Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13048-025-01631-4","article-title":"Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer","volume":"18","author":"Chen","year":"2025","journal-title":"J. Ovarian Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mao, H., and Yang, F. (2023). Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: A meta-analysis. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1193962"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"El Bairi, K., Al Jarroudi, O., and Afqir, S. (2021). Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.694821"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12672-025-02205-y","article-title":"The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: A retrospective cohort study based on the SEER database","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Puia, A., Pop, S.R., Manzat, B.O.C., Pintea, S., Puia, I.C., and Fadgyas-Stanculete, M. (2025). Coping Strategies Among Healthcare Workers During the COVID-19 Pandemic: Emotional Responses, Challenges, and Adaptive Practices. Medicina, 61.","DOI":"10.3390\/medicina61020311"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jso.27048","article-title":"Treatment delay and treatment pattern modifications among epithelial ovarian cancer patients during the COVID-19 pandemic: A retrospective cohort study","volume":"126","author":"Moterani","year":"2022","journal-title":"J. Surg. Oncol."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:27:14Z","timestamp":1775564834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diseases14040131"],"URL":"https:\/\/doi.org\/10.3390\/diseases14040131","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}